Antinori A - Search Results

1

A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients.

Eron JJ, Orkin C, Gallant J, Molina JM, Negredo E, Antinori A, Mills A, Reynes J, Van Landuyt E, Lathouwers E, Hufkens V, Jezorwski J, Vanveggel S, Opsomer M; AMBER study group. Eron JJ, et al. Among authors: antinori a. AIDS. 2018 Jul 17;32(11):1431-1442. doi: 10.1097/QAD.0000000000001817. AIDS. 2018. PMID: 29683855 Free PMC article. Clinical Trial.

2

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

Cingolani A, Antinori A, Rizzo MG, Murri R, Ammassari A, Baldini F, Di Giambenedetto S, Cauda R, De Luca A. Cingolani A, et al. Among authors: antinori a. AIDS. 2002 Feb 15;16(3):369-79. doi: 10.1097/00002030-200202150-00008. AIDS. 2002. PMID: 11834948 Clinical Trial.

3

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.

Mussini C, Bugarini R, Perno CF, Antinori A, Borghi V, Bertoli A, D'Arrigo R, Bedini A, Mongiardo N, Cossarizza A, Esposito R. Mussini C, et al. Among authors: antinori a. AIDS. 2002 Jul 26;16(11):1551-4. doi: 10.1097/00002030-200207260-00013. AIDS. 2002. PMID: 12131194 Clinical Trial.

4

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients.

Antinori A, Giancola ML, Grisetti S, Soldani F, Alba L, Liuzzi G, Amendola A, Capobianchi M, Tozzi V, Perno CF. Antinori A, et al. AIDS. 2002 Sep 27;16(14):1867-76. doi: 10.1097/00002030-200209270-00003. AIDS. 2002. PMID: 12351946

5

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

Girardi E, Palmieri F, Zaccarelli M, Tozzi V, Trotta MP, Selva C, Narciso P, Petrosillo N, Antinori A, Ippolito G. Girardi E, et al. Among authors: antinori a. AIDS. 2002 Sep 27;16(14):1976-9. doi: 10.1097/00002030-200209270-00021. AIDS. 2002. PMID: 12351964 No abstract available.

6

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy.

Liuzzi G, D'Offizi G, Topino S, Zaccarelli M, Amendola A, Capobianchi MR, Perno CF, Narciso P, Antinori A. Liuzzi G, et al. Among authors: antinori a. AIDS. 2003 May 2;17(7):1089-92. doi: 10.1097/00002030-200305020-00022. AIDS. 2003. PMID: 12700463

7

HIV Type 1 replication in cerebrospinal fluid of patients with AIDS-related non-Hodgkin's lymphoma receiving chemotherapy and antiretroviral therapy.

Giancola ML, Uccella I, Alba L, Lorenzini P, Soldani F, Capobianchi M, Ruco L, Perno CF, Antinori A. Giancola ML, et al. Among authors: antinori a. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1091-5. doi: 10.1089/088922203771881185. AIDS Res Hum Retroviruses. 2003. PMID: 14709245

8

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.

Mussini C, Bedini A, Borghi V, Guaraldi G, Esposito R, Barchi E, Enilia R, Cozzi-Lepri A, Philips AN, Ortolani P, Bratt G, Eriksson LE, Sighinolfi L, Cossarizza A, d'Arminio Monforte A, De Luca A, Di Giambenedetto S, Antinori A; International Study Group on CD4-monitored Treatment Interruptions. Mussini C, et al. Among authors: antinori a. AIDS. 2005 Feb 18;19(3):287-94. AIDS. 2005. PMID: 15718839

9

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients.

Zaccarelli M, Tozzi V, Lorenzini P, Trotta MP, Forbici F, Visco-Comandini U, Gori C, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test (GRT) at National Institute for Infectious Diseases Lazzaro Spallanzani. Zaccarelli M, et al. Among authors: antinori a. AIDS. 2005 Jul 1;19(10):1081-9. doi: 10.1097/01.aids.0000174455.01369.ad. AIDS. 2005. PMID: 15958840

10

Safety and efficacy of regimens containing emtricitabine in HIV-infected patients taking highly active antiretroviral therapy.

Marconi P, Lorenzini P, Borrelli I, Liuzzi G, Sette P, Zaccarelli M, Antinori A. Marconi P, et al. Among authors: antinori a. New Microbiol. 2006 Jul;29(3):169-75. New Microbiol. 2006. PMID: 17058783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

900 results

Search Page